Other Viruses Citation List: June 8 - June 21, 2012
Hepatitis B Virus
1. Deoxy Derivatives of L-like 5'-Noraristeromycin. Hinton, S., A. Riddick, and T. Serbessa, Tetrahedron Letters, 2012. 53(14): p. 1753-1755; PMID[22711940].
[PubMed]. OV_0608-062112.
2. Anti-Hepatitis B Virus Effect and Possible Mechanism of Action of 3,4-O-Dicaffeoylquinic Acid in Vitro and in Vivo. Wu, Y.H., B.J. Hao, H.C. Cao, W. Xu, Y.J. Li, and L.J. Li, Evidence-Based Complementary and Alternative Medicine, 2012. 2012: p. 356806; PMID[22701506].
[PubMed]. OV_0608-062112.
3. Design, Synthesis, and Molecular Hybrids of Caudatin and Cinnamic Acids as Novel anti-Hepatitis B Virus Agents. Wang, L.J., C.A. Geng, Y.B. Ma, J. Luo, X.Y. Huang, H. Chen, N.J. Zhou, X.M. Zhang, and J.J. Chen, European Journal of Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22687441].
[PubMed]. OV_0608-062112.
Hepatitis C Virus
4. TMC647055, A Potent Non-nucleoside HCV NS5B Polymerase Inhibitor with Cross-genotypic Coverage. Devogelaere, B., J.M. Berke, L. Vijgen, P. Dehertogh, E. Fransen, E. Cleiren, L. van der Helm, O. Nyanguile, A. Tahri, K. Amssoms, O. Lenz, M.D. Cummings, R.F. Clayton, S. Vendeville, P. Raboisson, K.A. Simmen, G.C. Fanning, and T.I. Lin, Antimicrobial Agents and Chemotherapy, 2012. [Epub ahead of print]; PMID[22710121].
[PubMed]. OV_0608-062112.
5. Synthesis and Evaluation of Novel Potent HCV NS5A Inhibitors. Zhang, H., L. Zhou, F. Amblard, J. Shi, D.R. Bobeck, S. Tao, T.R. McBrayer, P.M. Tharnish, T. Whitaker, S.J. Coats, and R.F. Schinazi, Bioorganic & Medicinal Chemistry Letters, 2012. [Epub ahead of print]; PMID[22704887].
[PubMed]. OV_0608-062112.
6. Identification of Non-macrocyclic Small Molecule Inhibitors against the NS3/4A Serine Protease of Hepatitis C Virus through In-silico Screening.. Chaudhuri, R., H. Lee, L. Truong, J. Torres, K.K. Patel, and M.E. Johnson, Journal of Chemical Information and Modeling, 2012. [Epub ahead of print]; PMID[22697413].
[PubMed]. OV_0608-062112.
7. Total Synthesis of a Noricumazole A Library and Evaluation of HCV Inhibition. Barbier, J., J. Wegner, S. Benson, J. Gentzsch, T. Pietschmann, and A. Kirschning, Chemistry (Weinheim an der Bergstrasse, Germany), 2012. [Epub ahead of print]; PMID[22696300].
[PubMed]. OV_0608-062112.
8. Inhibition of Hepatitis C Virus Replication and Viral Helicase by Ethyl Acetate Extract of the Marine Feather Star Alloeocomatella polycladia. Yamashita, A., K.A. Salam, A. Furuta, Y. Matsuda, O. Fujita, H. Tani, Y. Fujita, Y. Fujimoto, M. Ikeda, N. Kato, N. Sakamoto, S. Maekawa, N. Enomoto, M. Nakakoshi, M. Tsubuki, Y. Sekiguchi, S. Tsuneda, N. Akimitsu, N. Noda, J. Tanaka, and K. Moriishi, Marine Drugs, 2012. 10(4): p. 744-61; PMID[22690141].
[PubMed]. OV_0608-062112.
SIV
9. Response of SIV to the Novel Nucleoside Reverse Transcriptase Inhibitor 4' -Ethynyl-2-fluoro-2' -deoxyadenosine (EFdA) in Vitro and in Vivo. Murphey-Corb, M., P. Rajakumar, H. Michael, J. Nyaundi, P.J. Didier, A.B. Reeve, H. Mitsuya, S.G. Sarafianos, and M.A. Parniak, Antimicrobial Agents and Chemotherapy, 2012. [Epub ahead of print]; PMID[22713337].
[PubMed]. OV_0608-062112.
Human Cytomegalovirus
10. 17-Allylamino-17-(demethoxy)geldanamycin (17-AAG) is a Potent and Effective Inhibitor of Human Cytomegalovirus Replication in Primary Fibroblast Cells. Evers, D.L., C.F. Chao, Z. Zhang, and E.S. Huang, Archives of Virology, 2012. [Epub ahead of print]; PMID[22711259].
[PubMed]. OV_0608-062112.
HSV-1
11. Anti-Herpes Simplex Virus Efficacies of 2-Aminobenzamide Derivatives as Novel HSP90 Inhibitors. Xiang, Y.F., C.W. Qian, G.W. Xing, J. Hao, M. Xia, and Y.F. Wang, Bioorganic & Medicinal Chemistry Letters, 2012. [Epub ahead of print]; PMID[22704890].
[PubMed]. OV_0608-062112.
12. Structural Characterization and anti-HSV-1 and HSV-2 Activity of Glycolipids from the Marine Algae Osmundaria obtusiloba Isolated from Southeastern Brazilian Coast. de Souza, L.M., G.L. Sassaki, M.T. Romanos, and E. Barreto-Bergter, Marine Drugs, 2012. 10(4): p. 918-31; PMID[22690151].
[PubMed]. OV_0608-062112.
Citations from the ISI Web of Knowledge Listings for O.V.
13. Intramolecular Regulation of the Sequence-specific mRNA Interferase Activity of MazF Fused to a MazE Fragment with a Linker Cleavable by Specific Proteases. Park, J.H., Y. Yamaguchi, and M. Inouye, Applied and Environmental Microbiology, 2012. 78(11): p. 3794-3799; ISI[000304185400002].
[WOS]. OV_0608-062112.
14. Non-hydrolysable Analogues of Inorganic Pyrophosphate as Inhibitors of Hepatitis C Virus RNA-dependent RNA-polymerase. Yanvarev, D.V., A.N. Korovina, N.N. Usanov, and S.N. Kochetkov, Russian Journal of Bioorganic Chemistry, 2012. 38(2): p. 224-229; ISI[000304409900015].
[WOS]. OV_0608-062112.